Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Procedure Type, Application & End-User The global atherectomy devices market will witness a robust CAGR of 7.34%, valued at $1.02 billion in 2021, expected to appreciate and reach $2.01 billion by 2030, confirms Strategic Market Research. North America had the highest industry share of 75.83%. Atherectomy is a method that uses a catheter with a sharp blade on the end that removes plaque from a blood vessel. The patient is first sedated. The surgeon then gently inserts the catheter into the patient’s body, usually in the groin or upper thigh. The catheter is then guided gently through the blood vessels into the heart. Once the catheter is at the required position, dye is injected through the catheter into the coronary arteries. An X-ray is conducted to determine the blocked or narrowed area. The surgeon uses tiny blades or lasers attached to the end of the catheter to remove plaque. A study shows over 190,000 atherectomy procedures are performed yearly in the US. This number is expected to surge owing to the increasing prevalence of atherosclerosis among the masses. Drivers - Rising Prevalence of Diseases and Geriatric Population, Growing Preference for minimally invasive surgical procedures, and Higher Success Rate The world's population has a rising frequency of arterial diseases (peripheral artery disease, coronary artery disease). According to the NCBI, more than 200 million people have peripheral artery disease (PAD) worldwide. In addition, there has been a notable rise in the geriatric population. According to Statistics Canada, 18.5% of the Canadian population will be 65 and older in 2021 and more prone to coronary artery disease. This has increased the demand for Atherectomy devices, thus augmenting the industry growth. Recently, doctors and patients have increased the adoption of minimally invasive procedures like atherectomy. Hence, the demand for Atherectomy devices has increased, which extensively accelerates the atherectomy devices market growth. According to an American Heart Association (AHA) study, Atherectomy devices were 94.7% successful in treating patients. Thus, market growth is expected to increase rapidly with a higher success rate. Restraints - High Costs, High Restenosis Rate The high costs of atherectomy force patients to prefer other methods of treatment. According to an NCBI study, the average angioplasty cost is around USD 7300. In contrast, the average cost of atherectomy is USD 9300. The high costs impact the demand for atherectomy, which impedes the market growth. Atherectomy has a high success rate, but its high restenosis rate force patients to opt for other treatment methods, thus slowing down the market growth. According to a study published in AHA, atherectomy had a 37.7% restenosis rate. Opportunities - Improved Technologies With newer and improved Atherectomy devices, the industry growth can be accelerated to provide further opportunities for growth. Processes like Percutaneous Revascularisation using treatment principles such as optical coherence tomography and interventional radiology could be used to improve Atherectomy devices. In addition, Atherectomy systems like thrombectomy devices and Vitrectomy devices could also be used. According to Healthline, the success rate of vitrectomy is 90%, even for patients over 60 years old. Market Analysis Of Different Segments Covered in the Report Based on Type Directional Coronary Atherectomy Rotational Atherectomy Orbital Atherectomy Laser Atherectomy Based on Application Peripheral Vascular Applications Cardiovascular Applications Neurovascular Applications Based on End-User Hospitals and Surgical Centres Ambulatory Care Centres Other End Users Regional Coverage Analysis North America United States of America Canada Mexico Rest of North America Europe United Kingdom Germany France Italy Rest of Europe Asia-Pacific Japan China India Rest of APAC LAMEA Argentina Brazil UAE Rest of LAMEA Segments Analysis & Insights Based on type, the orbital atherectomy segment held the largest industry size, with almost 30% in 2020. Orbital atherectomy is an adjunctive technique used for the lesion preparation of calcified plaque. This is done to avoid percutaneous coronary intervention and peripheral percutaneous endovascular interventions. According to a research study published by the American Heart Association, the success rate of orbital atherectomy was 99%. On the other hand, the laser atherectomy market is expected to grow the fastest with a CAGR of 7% due to its suitability for clinical benefits offered and ongoing increasing developments in directional Atherectomy technology. According to a study, 24% of all atherectomy procedures were done using a laser. The peripheral vascular applications segment is expected to contribute a significant market share based on application. This segment is expected to register the maximum CAGR of 6.71% due to its attribution to increasing acceptance of atherectomy to treat cardiac and peripheral vascular diseases over the forecasted period. Based on the end-user, hospitals and surgical centers are estimated to have the highest revenue share in the global Atherectomy devices market, with a revenue CAGR of more than 6.63% during the forecasted period because of an observed rise in Atherectomy acceptability for the treatment of cardiac and peripheral vascular diseases throughout the forecasted period. The North American region had the highest market share of 75.83%. The rising number of cardiovascular, neurovascular, and peripheral diseases, better technology, and more trained medical professionals in atherectomy contributed to the industry's growth. According to the CDC, around 6.5 million people aged 40 and older have peripheral artery disease in the USA. Asia-Pacific is forecasted to have the maximum industry growth from 2020 to 2030, with a CAGR of 8.2%. Socioeconomic changes, unhealthy diet, liquor intake, smoking, and demographic aging have increased target diseases and increased demand for the overall market. According to an NCBI study, 4.77 million Indians will have cardiovascular diseases in 2020. Atherectomy Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 1.06 billion The revenue forecast in 2030 USD 2.01 billion Growth rate CAGR of approximately 8.2% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Type, By Application, By End-Use, By Region By Type Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy By Application Peripheral Vascular Applications, Cardiovascular Applications, Neurovascular Applications By End-Use Hospitals and Surgical Centres, Ambulatory Care Centres, Other End Users By Region Asia Pacific, North America, Europe, LAMEA Country Scope United States of America, Canada, Mexico, United Kingdom, Germany, France, Italy, Japan, India, China, Argentina, Brazil, United Arab Emirates Company Usability Profiles Abbott Laboratories, Boston Scientific Corporation, Medtronic, Becton, Dickinson and Company (BD Interventional), Koninklijke Philips N.V., Avinger, Inc., Rex Medical, AngioDynamics Cost & acquiring options Get hold of customized purchase options to fulfill your niche research needs. Atherectomy Devices Market Competitive Landscape Analysis The industry is moderately competitive, with many key players in the market. Some major companies that are currently operating in this market are: Abbott Laboratories Boston Scientific Corporation Medtronic Becton, Dickinson, and Company (BD Interventional) Koninklijke Philips N.V. Avinger, Inc. Rex Medical AngioDynamics Recent Developments On August, 2022, AngioDynamics announced that it had received FDA approval for launching its highly advanced Auryon-Atherectomy System. AngioDynamics is further planning to launch Auryon System’s 2.35 mm and 2.0 mm catheters to treat arterial thrombosis. Both the catheters are highly efficient as atherectomy conducting devices and can also be used to treat ISR /In-Stent Restenosis. In April 2022, AngioDynamics, Inc. announced a new clinical study to assess its Auryon Atherectomy system to treat calcified lesions in below-the-knee arteries. AngioDynamics believes that the study will further enhance and confirm the efficacy and versatility of Auryon while effectively treating patients and helping them improve their way of life. In February 2022, Cardiovascular Systems, Inc. (CSI) announced its collaboration with Innova Vascular, Inc. to develop a full line of novel thrombectomy devices. Innova believes that the collaboration with CSI would allow it to leverage CSI’s commercial presence in the thrombectomy devices market to accelerate the commercialization of Innova’s products after receiving regulatory clearances. In November 2021, Avinger Inc. announced it had received FDA 510 (k) clearance for its Pantheris image-guided atherectomy system to treat in-stent restenosis in the lower extremity arteries. Avinger believes that the clearance will allow the company to expand its addressable market to include a high-incidence disease state for which only a few treatment options are available. In October 2021. Becton, Dickinson, and Company (BD Interventional) announced that it had received FDA 510 (k) clearance for its Rotarex Atherectomy System to treat in-stent restenosis in peripheral arteries. BD believes that the clearance will provide physicians with an ideal solution to treat complex lesions associated with peripheral artery disease and demonstrates its responsibility to develop new technology to fight against peripheral artery disease. In September 2021, Boston Scientific Corporation announced the acquisition of Devoro Medical for approximately USD 336 million. Boston Scientific believes that the acquisition of Devoro will allow it to leverage Devoro’s WOLF thrombectomy platform to advance its efforts to ensure clinicians have the necessary tools to improve product efficiency. Various Leading Atherectomy Devices that Key Market Leaders Develop Name of the Product Function Key Player Auryon Atherectomy System Catheter Treatment of above-the-knee calcified lesions AngioDynamics Pantheris Image-Guided Atherectomy Avinger, Inc. Crosser Catheter S6 Facilitates intraluminal placement of conventional guidewires beyond peripheral artery chronic total occlusions (CTO) via atherectomy Becton, Dickinson, and Company (BD Interventional) Turbo-Elite Laser Atherectomy Catheter Treatment of multiple lesion morphologies within PAD lesions using ultraviolet radiation Koninklijke Philips NV Revolutionary Peripheral Atherectomy System Ablation and removal of thrombus and atherosclerotic plaque from peripheral arteries Rex Medical, Inc. Frequently Asked Question About This Report What are the types of atherectomy? The types of atherectomy are directional, rotational, orbital, and laser atherectomy. What is the success rate for atherectomy? The success rate of atherectomy was found to be greater than 96%. What is the atherectomy devices market growth? The global atherectomy devices market is expected to grow at a compound annual growth rate (CAGR) of 7.34% from 2021 to 2030 to reach USD2.01 billion by 2030. What is orbital atherectomy? Orbital atherectomy is an adjunctive process used to prepare lesions before percutaneous coronary infection and peripheral percutaneous endovascular intervention. How big is the atherectomy devices market? The global atherectomy devices market size was $1.06 Bn in 2021 and is predicted to reach $2.01 Bn by 2030, with a CAGR of 7.34%. What are atherectomy devices? Atherectomy devices are those devices that are used to remove the thrombus and plaque from a blood vessel. Why is the laser product segment across the market witnessing significant expansion? The laser product segment across the market is witnessing significant expansion because it is found to be suitable for clinical benefits offered and the ongoing increasing developments of directional atherectomy technology. Sources https://www.ahajournals.org/doi/10.1161/01.cir.102.21.2593 https://www.healthline.com/health/vitrectomy https://www.ncbi.nlm.nih.gov/books/NBK557482/ https://www150.statcan.gc.ca/n1/daily-quotidien/220822/dq220822b-eng.htm https://www.ahajournals.org/doi/10.1161/01.CIR.96.1.128 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Atherectomy Devices Market 4.2.1 Global market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global market, by Region, 2021-2030 (USD Million) 4.4 By Type Business Analysis 4.4.1 Global market, By Type, 2021-2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 Global market, By End-User, 2021-2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Global market, By Application, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 market PEST analysis 4.9.2 market Porter’s analysis 4.10Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2020) 5.11.2. Trends in Application (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Directional Atherectomy 7.3.1. Directional Atherectomy market, 2021-2030 (USD Million) 7.4. Rotational Atherectomy 7.4.1. Rotational Atherectomy market, 2021-2030 (USD Million) 7.5. Orbital Atherectomy 7.5.1. Orbital Atherectomy market, 2021-2030 (USD Million) 7.6. Laser Atherectomy 7.6.1. Laser Atherectomy market, 2021-2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals and Surgical Centres 8.3.1. Hospitals and Surgical Centresmarket, 2021-2030 (USD Million) 8.4. Ambulatory Care Centres 8.4.1. Ambulatory Care Centresmarket, 2021-2030 (USD Million) 8.5. Other End Users 8.5.1. Other End Users market, 2021-2030 (USD Million) 9. Global Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Peripheral Vascular 9.3.1. Peripheral Vascularmarket, 2021-2030 (USD Million) 9.4. Cardiovascular 9.4.1. Cardiovascularmarket, 2021-2030 (USD Million) 9.5. Neurovascular 9.5.1. Neurovascularmarket, 2021-2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America market, by By Type, 2021-2030 (USD Million) 10.1.2. North America market, by By End-User, 2021-2030 (USD Million) 10.1.3. North America market, by Application, 2021-2030 (USD Million) 10.1.4. North America market, by Country, 2021-2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. market, by By Type, 2021-2030 (USD Million) 10.1.4.1.2. U.S. market, by By End-User, 2021-2030 (USD Million) 10.1.4.1.3. U.S. market, by Application, 2021-2030 (USD Million) 10.1.4.2.Canada 10.1.4.2.1. Canada market, by By Type, 2021-2030 (USD Million) 10.1.4.2.2. Canada market, by By End-User, 2021-2030 (USD Million) 10.1.4.2.3. Canada market, by Application, 2021-2030 (USD Million) 10.2. Europe 10.2.1. Europe market, by By Type, 2021-2030 (USD Million) 10.2.2. Europe market, by By End-User, 2021-2030 (USD Million) 10.2.3. Europe market, by Application, 2021-2030 (USD Million) 10.2.4. Europe market, by country, 2021-2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. market, by By Type, 2021-2030 (USD Million) 10.2.4.1.2. U.K. market, by By End-User, 2021-2030 (USD Million) 10.2.4.1.3. U.K. market, by Application, 2021-2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany market, by By Type, 2021-2030 (USD Million) 10.2.4.2.2. Germany market, by By End-User, 2021-2030 (USD Million) 10.2.4.2.3. Germany market, by Application, 2021-2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France market, by By Type, 2021-2030 (USD Million) 10.2.4.3.2. France market, by By End-User, 2021-2030 (USD Million) 10.2.4.3.3. France market, by Application, 2021-2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe market, by By Type, 2021-2030 (USD Million) 10.2.4.4.2. Rest of Europe market, by By End-User, 2021-2030 (USD Million) 10.2.4.4.3. Rest of Europe market, by Application, 2021-2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific market, by By Type, 2021-2030 (USD Million) 10.3.2. Asia Pacific market, by By End-User, 2021-2030 (USD Million) 10.3.3. Asia Pacific market, by Application, 2021-2030 (USD Million) 10.3.4. Asia Pacific market, by country, 2021-2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China market, by By Type, 2021-2030 (USD Million) 10.3.4.1.2. China market, by By End-User, 2021-2030 (USD Million) 10.3.4.1.3. China market, by Application, 2021-2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India market, by By Type, 2021-2030 (USD Million) 10.3.4.2.2. India market, by By End-User, 2021-2030 (USD Million) 10.3.4.2.3. India market, by Application, 2021-2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan market, by By Type, 2021-2030 (USD Million) 10.3.4.3.2. Japan market, by By End-User, 2021-2030 (USD Million) 10.3.4.3.3. Japan market, by Application, 2021-2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea market, by By Type, 2021-2030 (USD Million) 10.3.4.4.2. South Korea market, by By End-User, 2021-2030 (USD Million) 10.3.4.4.3. South Korea market, by Application, 2021-2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC market, by By Type, 2021-2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC market, by By End-User, 2021-2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC market, by Application, 2021-2030 (USD Million) 10.4. Latin America 10.4.1. Latin America market, by By Type, 2021-2030 (USD Million) 10.4.2. Latin America market, by By End-User, 2021-2030 (USD Million) 10.4.3. Latin America market, by Application, 2021-2030 (USD Million) 10.4.4. Latin America market, by country, 2021-2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil market, by By Type, 2021-2030 (USD Million) 10.4.4.1.2. Brazil market, by By End-User, 2021-2030 (USD Million) 10.4.4.1.3. Brazil market, by Application, 2021-2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico market, by By Type, 2021-2030 (USD Million) 10.4.4.2.2. Mexico market, by By End-User, 2021-2030 (USD Million) 10.4.4.2.3. Mexico market, by Application, 2021-2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America market, by By Type, 2021-2030 (USD Million) 10.4.4.3.2. Rest of the Latin America market, by By End-User, 2021-2030 (USD Million) 10.4.4.3.3. Rest of the Latin America market, by Application, 2021-2030 (USD Million) 10.5. LAMEA 10.5.1. LAMEA market, by By Type, 2021-2030 (USD Million) 10.5.2. LAMEA market, by By End-User, 2021-2030 (USD Million) 10.5.3. LAMEA market, by Application, 2021-2030 (USD Million) 10.5.4. LAMEA market, by Region, 2021-2030 (USD Million) 11. Competitive Landscape 11.1 Koninklijke Philips N.V.ott LaboratoriesBoston Scientific Corporation 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. MEDTRONIC 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. BECTON, DICKINSON AND COMPANY (BD INTERVENTIONAL) 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. KONINKLIJKE PHILIPS N.V. 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. AVINGER, INC. 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Rex Medical 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. AngioDynamics 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development List of Tables (48 Tables) TABLE 1. MARKET, By Type, 2021-2030 (USD Million) TABLE 2. MARKET FOR Directional Atherectomy, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Rotational Atherectomy, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Orbital Atherectomy, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET, By End-User, 2021-2030 (USD Million) TABLE 6. MARKET FOR Hospitals and Surgical Centres, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Ambulatory Care Centres, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET FOR Other End Users, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Food & Beverages, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Peripheral Vascular, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Cardiovascular, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Neurovascular, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Quality Testing, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET FOR Battery Powered , BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA MARKET, By Type, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 23. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 24. EUROPE MARKET, By Type, 2021-2030 (USD Million) TABLE 25. EUROPE MARKET, By End-User, 2021-2030 (USD Million) TABLE 26. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC MARKET, By Type, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 31. LALAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 32. LALAMEA MARKET, By Type, 2021-2030 (USD Million) TABLE 33. LALAMEA MARKET, By End-User, 2021-2030 (USD Million) TABLE 34. LALAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 35. Koninklijke Philips N.V.ott LaboratoriesBoston Scientific Corporation: COMPANY SNAPSHOT TABLE 36. Koninklijke Philips N.V.ott LaboratoriesBoston Scientific Corporation: OPERATING SEGMENTS TABLE 37. MEDTRONIC: COMPANY SNAPSHOT TABLE 38. MEDTRONIC: OPERATING SEGMENTS TABLE 39. BECTON, DICKINSON AND COMPANY (BD INTERVENTIONAL): COMPANY SNAPSHOT TABLE 40. BECTON, DICKINSON AND COMPANY (BD INTERVENTIONAL): OPERATING SEGMENTS TABLE 41. KONINKLIJKE PHILIPS N.V. : COMPANY SNAPSHOT TABLE 42. KONINKLIJKE PHILIPS N.V. : OPERATING SEGMENTS TABLE 43. AVINGER, INC.: COMPANY SNAPSHOT TABLE 44. AVINGER, INC.: OPERATING SEGMENTS TABLE 45. Rex Medical: COMPANY SNAPSHOT TABLE 46. Rex Medical: OPERATING SEGMENTS TABLE 47. AngioDynamics: COMPANY SNAPSHOT TABLE 48. AngioDynamics: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 7 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for , By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for , By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Type, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Orbital Atherectomy to Witness Higher CAGR in the Market for Type Segment during Forecast Period. Figure 16 Peripheral Vascular to Witness Higher CAGR in the Market for Application Segment during Forecast Period. Figure 17 Hospitals and Surgical Centres to Witness Higher CAGR in the Market for End-User Segment during Forecast Period. Figure 18 APAC Region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview